Gloucester Marine Genomics Institute: Andrew Gardner, Christopher Taron

Andrew Gardner has been appointed as the inaugural CSO of the Gloucester Marine Genomics Institute (GMGI), a nonprofit organization that focuses on challenges facing the oceans, human health, and the environment. He joins GMGI from New England Biolabs, where he spent 28 years, most recently as scientific director of molecular enzymology.

GMGI also appointed Christopher Taron as senior director of protein science and innovation. He is the former director of protein expression and modification research at New England Biolabs.